ReP USP - Resultado da busca

Artigo de periodico
Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort (2022)
Ximenez, João Paulo Bianchi; Elias, Anna Beatriz Ribeiro; Nardotto, Glauco Henrique Balthazar ; Barroso, Paulo Feijó; Bollela, Valdes Roberto; Lanchote, Vera Lucia ; Suarez-Kurtz, Guilherme
Fonte: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Assuntos: FARMACOCINÉTICA, HIV, CITOCROMO P-450, GENÓTIPOS, INFECÇÕES POR HIV, FARMACOGENÉTICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIMENEZ, João Paulo Bianchi et al. Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort. British Journal of Clinical Pharmacology, v. 88, n. 10, p. 4585-4594, 2022Tradução . . Disponível em: https://doi.org/10.1111/bcp.15387. Acesso em: 22 jul. 2024.
APA
Ximenez, J. P. B., Elias, A. B. R., Nardotto, G. H. B., Barroso, P. F., Bollela, V. R., Lanchote, V. L., & Suarez-Kurtz, G. (2022). Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort. British Journal of Clinical Pharmacology, 88( 10), 4585-4594. doi:10.1111/bcp.15387
NLM
Ximenez JPB, Elias ABR, Nardotto GHB, Barroso PF, Bollela VR, Lanchote VL, Suarez-Kurtz G. Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 10): 4585-4594.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1111/bcp.15387
Vancouver
Ximenez JPB, Elias ABR, Nardotto GHB, Barroso PF, Bollela VR, Lanchote VL, Suarez-Kurtz G. Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 10): 4585-4594.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1111/bcp.15387
Artigo de periodico
Normative reference values of handgrip strength for Brazilian older people aged 65 to 90 years: evidence from the multicenter Fibra-BR study (2021)
Reichenheim, Michael Eduardo; Lourenço, Roberto Alves; Nascimento, Janaína Santos; Moreira, Virgílio Garcia; Neri, Anita Liberalesso; Ribeiro, Rodrigo Martins; Lustosa, Lygia Paccini; Ferriolli, Eduardo
Fonte: PLOS ONE. Unidade: FMRP
Assuntos: ENVELHECIMENTO, FORÇA MUSCULAR, MÃO, FATORES DE RISCO, POLINÔMIOS, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REICHENHEIM, Michael Eduardo et al. Normative reference values of handgrip strength for Brazilian older people aged 65 to 90 years: evidence from the multicenter Fibra-BR study. PLOS ONE, v. 16, n. 5, p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0250925. Acesso em: 22 jul. 2024.
APA
Reichenheim, M. E., Lourenço, R. A., Nascimento, J. S., Moreira, V. G., Neri, A. L., Ribeiro, R. M., et al. (2021). Normative reference values of handgrip strength for Brazilian older people aged 65 to 90 years: evidence from the multicenter Fibra-BR study. PLOS ONE, 16( 5), 1-17. doi:10.1371/journal.pone.0250925
NLM
Reichenheim ME, Lourenço RA, Nascimento JS, Moreira VG, Neri AL, Ribeiro RM, Lustosa LP, Ferriolli E. Normative reference values of handgrip strength for Brazilian older people aged 65 to 90 years: evidence from the multicenter Fibra-BR study [Internet]. PLOS ONE. 2021 ; 16( 5): 1-17.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1371/journal.pone.0250925
Vancouver
Reichenheim ME, Lourenço RA, Nascimento JS, Moreira VG, Neri AL, Ribeiro RM, Lustosa LP, Ferriolli E. Normative reference values of handgrip strength for Brazilian older people aged 65 to 90 years: evidence from the multicenter Fibra-BR study [Internet]. PLOS ONE. 2021 ; 16( 5): 1-17.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1371/journal.pone.0250925
Artigo de periodico
gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly (2021)
Wildemberg, Luiz Eduardo; Henriques, Daniel; Elias, Paula Conde Lamparelli; Lima, Carlos Henrique de A.; Musolino, Nina R. de Castro; Camacho, Aline Helen Silva; Faria, Olivia; Nazato, Debora; Abucham, Julio; Vilar, Lucio; Mota, Jose Italo; Huayllas, Martha Katherine P.; Chimelli, Leila; Castro, Margaret de ; Kasuki, Leandro; Gadelha, Mônica R.
Fonte: Cancers. Unidade: FMRP
Assuntos: MUTAÇÃO GENÉTICA, ACROMEGALIA, SOMATOSTATINA, BIOMARCADORES, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDEMBERG, Luiz Eduardo et al. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, v. 13, n. 19, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13194857. Acesso em: 22 jul. 2024.
APA
Wildemberg, L. E., Henriques, D., Elias, P. C. L., Lima, C. H. de A., Musolino, N. R. de C., Camacho, A. H. S., et al. (2021). gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, 13( 19), 1-11. doi:10.3390/cancers13194857
NLM
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 jul. 22 ] Available from: https://doi.org/10.3390/cancers13194857
Vancouver
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 jul. 22 ] Available from: https://doi.org/10.3390/cancers13194857
Artigo de periodico
Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach (2020)
Coelho, Eduardo Barbosa ; Cusinato, Diego Alberto Ciscato ; Ximenez, João Paulo Bianchi ; Lanchote, Vera Lucia ; Struchiner, Claudio José; Suarez-Kurtz, Guilherme
Fonte: Frontiers in Pharmacology. Unidades: FMRP, FCFRP
Assuntos: CAFEÍNA, ANTI-HISTAMÍNICOS, FÁRMACOS (SISTEMA DIGESTÓRIO), FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Eduardo Barbosa et al. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach. Frontiers in Pharmacology, v. 11, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.00022. Acesso em: 22 jul. 2024.
APA
Coelho, E. B., Cusinato, D. A. C., Ximenez, J. P. B., Lanchote, V. L., Struchiner, C. J., & Suarez-Kurtz, G. (2020). Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach. Frontiers in Pharmacology, 11, 1-7. doi:10.3389/fphar.2020.00022
NLM
Coelho EB, Cusinato DAC, Ximenez JPB, Lanchote VL, Struchiner CJ, Suarez-Kurtz G. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-7.[citado 2024 jul. 22 ] Available from: https://doi.org/10.3389/fphar.2020.00022
Vancouver
Coelho EB, Cusinato DAC, Ximenez JPB, Lanchote VL, Struchiner CJ, Suarez-Kurtz G. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-7.[citado 2024 jul. 22 ] Available from: https://doi.org/10.3389/fphar.2020.00022

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada